Head-to-head · WeighScore
No BS RX vs Walgreens Weight Management
By GLP-1 ScorecardUpdated
Score comparison
No BS RX has the higher recorded score — 82.8/100 to 62.8/100.
No BS RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. No BS RX publishes separate prices for standard compounded, low-dose and brand-name programs.
Before you choose
Before comparing the headline prices, the No BS RX review and the Walgreens Weight Management review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, No BS RX vs WeightWatchers Clinic and Ro vs Walgreens Weight Management compare each of them with another graded program, and the list of alternatives to No BS RX ranks the programs closest to No BS RX on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the GoodLife Health review covers one graded close to these two, at 69.8/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | No BS RX | Walgreens Weight Management |
|---|---|---|
| WeighScore | 82.8/100 | 62.8/100 |
| Grade | B− | C |
| Site position | #23 | #288 |
| Semaglutide | $149/mo advertised for standard compounded injection; low-dose priced separately | Medication extra; $49 per visit; branded oral/injectable options with conditional savings |
| Tirzepatide | $225/mo advertised for standard compounded injection; low-dose priced separately | Medication extra; $49 per visit; dose-specific Zepbound savings and refill conditions |
| Coverage | Confirm program availability for your state | 48 states; excludes AL and LA; Medicare Bridge footprint differs |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Strengths
- Displays monthly and prepaid amounts by program
- Advertises consultation, medication, shipping and messaging in the compounded plans
- Lists branded Ozempic and Zepbound separately
What to consider
- The $115 headline applies to low-dose programs
- Plans renew automatically at the then-current rate
- Cancellation generally stops future billing without refunding the current period
Site position #288 · C
Strengths
- No subscription required; initial and follow-up visits are $49 each
- Branded injectable and oral treatment options
- Current weight-management page offers prior-authorization help for eligible commercially insured patients
What to consider
- Medication and any required testing cost extra; insurance does not pay the visit fee
- Generic help pages still conflict with the new prior-authorization offer
- Standard service excludes AL and LA; Medicare Bridge has more exclusions
- No refund solely because a clinician declines the requested prescription
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.